This article is more than 5 years old. Information may no longer be current.
Five articles celebrating National Heart Valve Disease Awareness Day
Click Here to Manage Email Alerts
February 22, 2017 marks the first annual National Heart Valve Disease Awareness Day, which will be celebrated on Capitol Hill in Washington, D.C.
The briefing will information about advances in heart valve disease research and treatments, stories from patients, and details about the awareness day.
Cardiology Today’s Intervention has compiled five stories on the advances and treatments in the field of heart valve disease research to help spread awareness.
TAVR with newer device shows similar safety, efficacy to other devices
In patients undergoing transcatheter aortic valve replacement for the treatment of severe aortic stenosis, a self-expanding nitinol system yields positive safety and efficacy results vs. the two technologies approved in the United States.
PERIGON: Novel surgical aortic valve shows positive 1-year outcomes
A novel pericardial surgical aortic valve was associated with favorable 1-year outcomes in patients with aortic valve disease, defined as moderate or greater aortic stenosis or aortic regurgitation.
AF linked to higher all-cause mortality, bleeding, rehospitalization rates after TAVR
Patients with atrial fibrillation who undergo TAVR appear to have significantly higher rates of all-cause mortality, bleeding and rehospitalization at 12 months vs. those without AF.
TVT registry: TAVR mortality risk, observed mortality show a decrease
In patients who underwent TAVR, both the projected risk for mortality and observed in-hospital mortality have decreased since 2012, according to the annual report of the Society of Thoracic Surgery/American College of Cardiology Transcatheter Valve Therapy registry.
ACC releases new guidance for assessing TAVR eligibility
The American College of Cardiology has released a guidance document for determining patient eligibility for TAVR.